Prof. Electra Gizeli interviewed at “Kathimetini” about the rapid COVID-19 test developed in Biosensors’ lab (check News menu for more).

Prof. Electra Gizeli talks to Y. Elafros at “Kathimetini” for the novel device and rapid molecular test developed in Biosensors’ lab for COVID-19 and for applications at the point-of-care.

Hybrid Sensor Device for Simultaneous Surface Plasmon Resonance and Surface Acoustic Wave Measurements by Samarentsis et al has just been published.

“Hybrid Sensor Device for Simultaneous Surface Plasmon Resonance and Surface Acoustic Wave Measurements” published on Sensors

The lab’s portable molecular diagnostic device ready to be commercially available for the detection of SARS-CoV-2 in the next few months, from FORTH’s spin off company BioPix-T.

The lab’s portable molecular diagnostic device is ready for commercial release in the next few months for the detection of SARS-CoV-2. An article in the Business section of the Greek newspaper Kathimerini is devoted on the new methodology and FORTH’s spin off company BioPix-T which has undertaken the commercial exploitation.

The lab is looking for two molecular biologists to work on the development of diagnostic assays for COVID 19/FLU and plant pathogens.

Two post-doc positions available. Look at the News section for more.

Extensive article in press regarding new test, EU funding and spin-out company, all related to Biosenosr lab. Further info in the relevant press release.

Biosensors lab was the recipient of significant European funding (2.3M€ in total) obtained under the emergency action for SARS-CoV-2 outbreak. The work, which will be coordinated by FORTH and includes 7 more partners, was one of the 23 proposals selected for funding from a total of 454 submitted ones.